This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joakim Bergman: Innovator in GLP-1 Receptor Modulation
Introduction
Joakim Bergman is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate GLP-1 receptors. His work is crucial in addressing various metabolic conditions, including Type 2 diabetes.
Latest Patents
Bergman holds a patent for "Certain 2,5-diazabicyclo[4.2.0]octanes and octahydrofuro[3,4-b]pyrazines as GLP-1 receptor modulators." This patent discloses certain 2,5-diazabicyclo[4.2.0]octanes of formula (I) and octahydrofuro[3,4-b]pyrazines, along with their pharmaceutically acceptable salts. The patent also includes compositions containing these compounds and their therapeutic uses. These compounds are particularly useful in the treatment or prophylaxis of cardiovascular diseases and metabolic conditions.
Career Highlights
Bergman is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in healthcare, particularly in the management of chronic diseases.
Collaborations
Bergman collaborates with Johan Sundell, enhancing the research and development efforts within their team. Their combined expertise fosters innovation in the pharmaceutical industry.
Conclusion
Joakim Bergman is a prominent inventor whose work in GLP-1 receptor modulation has the potential to significantly impact the treatment of metabolic diseases. His contributions to AstraZeneca and the field of pharmaceuticals highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
